A carregar...
AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE–RELATED MACULAR DEGENERATION: The ARI2 Study
PURPOSE: To analyze the efficacy of aflibercept switch treatment for regression of pigment epithelial detachment (PED) in patients previously treated with ranibizumab. METHODS: Multicenter, prospective, nonrandomized clinical trial. One eye of patients presenting neovascular age–related macular dege...
Na minha lista:
Publicado no: | Retina |
---|---|
Main Authors: | , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Retina
2018
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6250287/ https://ncbi.nlm.nih.gov/pubmed/29190241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000001928 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|